Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-263-3 | CAS number: 15206-55-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
There are no studies available in which the toxicokinetic properties of the test substance were investigated. Based on the absence of adverse findings in toxicity studies, and the presence of functional groups for metabolism, a potential for bioaccumulation is unlikely. Further details for this assessments are given below.
Chemistry
The test substance (molecular weight of 164 Da) is a yellow liquid those water solubility (deionised water) is 2 g/l and the logPow 1.9 at pH 6.3. The vapour pressure at 20 °C was determined to be 2.3 Pa which is considered to be low compared to water or ethanol. No hydrolysis was observed in any aqueous test solution at different pH values.
Absorption
In acute oral and dermal toxicity studies, rats were administered to the test substance. Mortality and clinical signs of toxicity were observed only after oral application at a concentration of 10.000 mg/kg bw. Dermal application did not provoke any effect up to the limit dose, indicating primarily a low level of oral and dermal toxicity. The NOAEL in male and female rats in a subacute oral repeated dose study is 1000 mg/kg bw. Regarding the results of the hydrolysis study mentioned above, hydrolytic degradation in the stomach is not expected. As the test item does not bear resemblance to fatty acids, uptake via micelles with bile acids is unlikely.
A slight skin penetration is expected based on a calculation according to the model of Fitzpatrick, et al., 2004.
Due to the low vapour pressure evaporation and subsequent respiratory uptake of the test item is not expected. In an animal study rats were exposed to vapour for 7h. Mortality of clinical signs of toxicity were not observed.
Metabolism
A single dose of the test item was administered by gavage to male and female Wistar rats at concentrations of 10000, 6810, 4640, 3160 mg/kg bw. Mortality occurred at the highest dose level. The LD50 after oral administration is considered to be > 5000 mg/kg bw. Single dermal application did not provoke any effect and LD50 was considered to be > 2000 mg/kg bw. Additionally
male and female rats each were exposed to test item vapour for 7h. All animals survived until the scheduled necropsy date, clinical signs of toxicity were no observed and gross pathology did not reveal any findings
Oral administration of the test substance to Wistar rats at doses of 100, 300 and 1000 mg/kg/day, for 28 days resulted in no test item-related effects and no differences in food consumption or body weight development. The hematology, clinical biochemistry and urinalysis parameters did not show test item-related differences when compared with those of the controls. Organ weights of test item-treated animals were unaffected, and macroscopical/microscopical findings were of no toxicological relevance. Based on the results of this study, 1000 mg/kg/day was considered to be the no observed- adverse-effect-level (NOAEL).
In case the substance is absorbed via the gastrointestianl system, the material will be transported to the liver. Enzymatic activity may result in hydroxylation of keto-groups and probably subsequent phase-II substitution by chlorine.
Excretion
In case of gastrointestinal uptake and metabolism through hydroxylation and phase-II substitution of chlorine it is expected that the test substance might be excreted predominantly via the urine. Overall, the test substance is not expected to accumulate in the body.
Used references:
Fitzpatrick, D., et al. (2004). "Modelling skin permeability in risk assessment-the future." Chemosphere 55 (10): 1309-14.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.